AJP - Endo AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 276: E472-E478, 1999;
0193-1849/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Constantin-Teodosiu, D.
Right arrow Articles by Greenhaff, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Constantin-Teodosiu, D.
Right arrow Articles by Greenhaff, P. L.
Vol. 276, Issue 3, E472-E478, March 1999

The importance of pyruvate availability to PDC activation and anaplerosis in human skeletal muscle

Dumitru Constantin-Teodosiu, Elizabeth J. Simpson, and Paul L. Greenhaff

School of Biomedical Sciences, University Medical School, Queen's Medical Center, Nottingham NG7 2UH, United Kingdom

No studies have singularly investigated the relationship between pyruvate availability, pyruvate dehydrogenase complex (PDC) activation, and anaplerosis in skeletal muscle. This is surprising given the functional importance attributed to these processes in normal and disease states. We investigated the effects of changing pyruvate availability with dichloroacetate (DCA), epinephrine, and pyruvate infusions on PDC activation and accumulation of acetyl groups and tricarboxylic acid (TCA) cycle intermediates (TCAI) in human muscle. DCA increased resting PDC activity sixfold (P < 0.05) but decreased the muscle TCAI pool (mmol/kg dry muscle) from 1.174 ± 0.042 to 0.747 ± 0.055 (P < 0.05). This was probably a result of pyruvate being diverted to acetyl-CoA and acetylcarnitine after near-maximal activation of PDC by DCA. Conversely, neither epinephrine nor pyruvate activated PDC. However, both increased the TCAI pool (1.128 ± 0.076 to 1.614 ± 0.188, P < 0.05 and 1.098 ± 0.059 to 1.385 ± 0.114, P < 0.05, respectively) by providing a readily available pool of pyruvate for anaplerosis. These data support the hypothesis that TCAI pool expansion is principally a reflection of increased muscle pyruvate availability and, together with our previous work (J. A. Timmons, S. M. Poucher, D. Constantin-Teodosiu, V. Worrall, I. A. Macdonald, and P. L. Greenhaff. J. Clin. Invest. 97: 879-883, 1996), indicate that TCA cycle expansion may be of little functional significance to TCA cycle flux. It would appear therefore that the primary effect of DCA on oxidative ATP provision is to provide a readily available pool of acetyl groups to the TCA cycle at the onset of exercise rather than increasing TCA cycle flux by expanding the TCAI pool.

dichloroacetate; epinephrine; pyruvate dehydrogenase complex; acetylcarnitine


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. J. Ellingson, D. G. Chesser, and W. W. Winder
Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E400 - E407.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. D. Dawson, K. R. Howarth, M. A. Tarnopolsky, N. D. Wong, and M. J. Gibala
Short-term training attenuates muscle TCA cycle expansion during exercise in women
J Appl Physiol, September 1, 2003; 95(3): 999 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Savasi, M. K. Evans, G. J. F. Heigenhauser, and L. L. Spriet
Skeletal muscle metabolism is unaffected by DCA infusion and hyperoxia after onset of intense aerobic exercise
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E108 - E115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Bruce, D. Constantin-Teodosiu, P. L. Greenhaff, L. H. Boobis, C. Williams, and J. L. Bowtell
Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E669 - E675.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. A. Morrison, L. L. Spriet, and D. J. Dyck
Pyruvate ingestion for 7 days does not improve aerobic performance in well-trained individuals
J Appl Physiol, August 1, 2000; 89(2): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Gibala, M. Lozej, M. A. Tarnopolsky, C. McLean, and T. E. Graham
Low glycogen and branched-chain amino acid ingestion do not impair anaplerosis during exercise in humans
J Appl Physiol, November 1, 1999; 87(5): 1662 - 1667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online